Company: IONQ
Filing Date: 2025-10-10
Form Type: 424B5
Source: 0001193125-25-236448
Chunk: 27

Company: IonQ, Inc.
Filing Date: 2025-10-10
Form: 424B5
Chunk 27
---
 July 9, 2025, and the issuance of the
applicable warrant shares); (ii) grants of stock options, stock awards, restricted stock, RSUs, or other equity awards and the issuance of shares of our common stock or securities convertible into or exercisable or exchangeable for shares of our
common stock (whether upon the exercise of stock options or otherwise) to our employees, officers, directors, advisors, or consultants pursuant to the terms of an equity compensation plan in effect as of the closing of this offering and described in
this prospectus supplement, provided that any such recipient who is an executive officer or director enter into a lock-up agreement with the underwriters covering the
60-day period; (iii) the issuance of, or submission to or filing with the Commission a registration statement under the Securities Act relating to, shares of common stock pursuant to acquisitions or other
similar strategic transactions that have been disclosed in the prospectus supplement; (iv) the issuance of, or submission to or filing with the Commission a registration statement under the Securities Act relating to, shares of common stock, or
securities convertible into, exercisable for, or which are otherwise exchangeable for, common stock, immediately following the closing of this offering, in acquisitions or other similar strategic transactions (including the entry into any agreement
providing for such issuance); (v) facilitating the establishment of a trading plan on behalf of a stockholder, officer, employee or director of the Company to pursuant to Rule 10b5-1 under the Exchange
Act for the sale, transfer or disposition of Common Stock; provided that such plan does not provide for the sale, transfer or disposition of Common Stock during the Restricted Period; or (vi) filing of any registration statement on Form S-8 relating to securities granted or to be granted pursuant to any plan in effect on the date of the underwriting agreement and described in this prospectus supplement or any assumed benefit plan pursuant
to an acquisition or similar strategic transaction.

Our directors and executive officers (such persons, the
“lock-up parties”) have entered into lock-up agreements with the underwriter prior to the commencement of this offering pursuant to which each lock-up party, with limited exceptions, for a period of 60 days after the date of this prospectus supplement (such period, the “restricted period”), may not (and may not cause any of their direct or
indirect affiliates to), without the prior written consent of the underwriter, (1) offer, pledge, sell,